We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Single-Dose IORT Offsets COVID-19 Compliance Issues

By MedImaging International staff writers
Posted on 07 Jan 2021
Print article
Image: The Zeiss Intrabeam 600 IORT system (Photo courtesy of Zeiss)
Image: The Zeiss Intrabeam 600 IORT system (Photo courtesy of Zeiss)
A long-term study show that targeted intraoperative radiotherapy (IORT) is equivalent to the traditional six-week radiotherapy (RT) regimen for early breast cancer (BC), reducing potential exposure to COVID-19.

Researchers at University College London (UCL; United Kingdom), Centro di Riferimento Oncologico di Aviano (CRO; Italy), and 30 other centers in 10 countries conducted a prospective, open label, randomized study to determine if single dose IORT during lumpectomy can effectively replace postoperative external beam radiotherapy (EBRT) for early BC. In all, 2,298 women with cN0-N1 invasive ductal carcinoma up to 3.5 cm in size were randomized before lumpectomy to risk adapted targeted IORT or EBRT.

The results demonstrated equal BC recurrence and survival rates among recipients of targeted IORT and those receiving multiple weeks of whole breast EBRT following lumpectomy. Long term follow-up of up to 18.9 years showed no significant difference in the five year local recurrence rates and 8.6 year local recurrence-free survival rates, BC survival rate, and overall survival rate. Women receiving targeted IORT also had a significantly lower risk of dying from other causes, such as heart disease or other cancers. The study was published on August 19, 2020, in BMJ.

“The long term results of this trial have shown that risk adapted single dose targeted IORT given during lumpectomy can effectively replace the mandatory use of several weeks of daily postoperative EBRT in patients with BC undergoing breast conservation,” concluded lead author Professor Jayant Vaidya, MD, of UCL, and colleagues. “Crucially, 80% of the patients required no additional radiotherapy; additionally, targeted IORT reduced non-breast cancer mortality. The advantage to the patient of avoiding post-operative radiotherapy could be considered obvious.”

“Unlike EBRT, which requires up to 30 visits to the radiotherapist, targeted IORT achieves the same clinical outcomes with one dose of targeted radiation delivered from inside the breast during surgery immediately following the removal of the tumor,” said Neil Friedman, MD, director of The Hoffberger Breast Center at Mercy Medical Center (Baltimore, MD, USA), who was not involved in the study. “Not only does targeted IORT mitigate the side effects normally associated with irradiating the entire breast multiple times, it may lessen or even eliminate unsafe additional outside trips during the pandemic.”

Related Links:
University College London
Centro di Riferimento Oncologico di Aviano



Print article
CIRS -  MIRION
Sun Nuclear -    Mirion

Channels

Radiography

view channel
Image: The FDA has cleared the CSA system with Dynamic Digital Radiography (Photo courtesy of 20/20 Imaging)

Advanced Digital X-Ray System Allows Clinicians to Capture and Visualize Anatomy in Motion

Dynamic Digital Radiography (DDR) is a revolutionary X-ray technology that enables the visualization of anatomy in motion, so clinicians can interpret the dynamic interaction of anatomical structures,... Read more

MRI

view channel
Image: MRI identifies patients with sarcoidosis at risk for bad cardiac outcomes (Photo courtesy of University of Minnesota Medical School)

MRI Identifies Patients at Higher Risk for Cardiac Sarcoidosis-Related Adverse Outcomes

Cardiac sarcoidosis is a rare inflammatory heart disease that can result in rhythm disturbances and heart failure. Researchers have now found that patients with certain features on magnetic resonance imaging... Read more

Ultrasound

view channel
Image: EG-740UT ultrasound endoscope combined with ARIETTA 850 provides outstanding ultrasound image quality (Photo courtesy of FUJIFILM)

Next-Gen Ultrasound Endoscope Enables Complex Diagnostic and Therapeutic Procedures

Endoscopic ultrasound is a specialist procedure performed utilizing an endoscope equipped with an ultrasonic transducer which emits and receives ultrasonic waves within the gastrointestinal tract, such... Read more

General/Advanced Imaging

view channel
Image: New guidance standardizes care for patients presenting with acute chest pain in the ED (Photo courtesy of Pexels)

New Guidance Recommends Coronary CTA as First-Line Test when Treating Acute Chest Pain in ED

Diagnosis and triage of emergency department (ED) patients with suspected acute coronary syndrome (ACS) consume a large and increasing amount of healthcare resources. ED overcrowding is associated with... Read more

Imaging IT

view channel
Illustration

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.